BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36343679)

  • 21. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
    Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
    Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notum leads to potential pro-survival of OSCC through crosstalk between Shh and Wnt/β-catenin signaling via p-GSK3β.
    Yang P; Li C; Zhou Q; Zhang X; Kou Y; Feng Q; Wang H; Su R; Hasegawa T; Liu H; Li M
    Int J Biochem Cell Biol; 2022 Dec; 153():106316. PubMed ID: 36280040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
    Wang X; Zhang Y; Zhang S; Duan L
    Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development.
    Sun S; Su G; Zheng X
    Mol Biotechnol; 2024 Feb; 66(2):208-221. PubMed ID: 37071303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway.
    Yang YT; Wang YF; Lai JY; Shen SY; Wang F; Kong J; Zhang W; Yang HY
    Cancer Sci; 2016 Nov; 107(11):1581-1589. PubMed ID: 27560546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer.
    Reed ER; Jankowski SA; Spinella AJ; Noonan V; Haddad R; Nomoto K; Matsui J; Bais MV; Varelas X; Kukuruzinska MA; Monti S
    Transl Res; 2023 Oct; 260():46-60. PubMed ID: 37353110
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Huang C; Wang L; Song H; Wu C
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3037-3042. PubMed ID: 31342798
    [No Abstract]   [Full Text] [Related]  

  • 31.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
    [No Abstract]   [Full Text] [Related]  

  • 32. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
    Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
    Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
    Wang LH; Xu M; Fu LQ; Chen XY; Yang F
    Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
    Kou Y; Zhang Y; Rong X; Yang P; Wang C; Zhou Q; Liu H; Liu B; Li M
    J Oral Biosci; 2023 Dec; 65(4):347-355. PubMed ID: 37625505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WDR5 promotes the tumorigenesis of oral squamous cell carcinoma via CARM1/β-catenin axis.
    Lyu XY; Shui YS; Wang L; Jiang QS; Meng LX; Zhan HY; Yang R
    Odontology; 2022 Jan; 110(1):138-147. PubMed ID: 34398317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification.
    Huang J; Li H; Yang Z; Liu R; Li Y; Hu Y; Zhao S; Gao X; Yang X; Wei J
    Cell Death Dis; 2024 Feb; 15(2):139. PubMed ID: 38355684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FUT8-AS1/miR-944/Fused in Sarcoma/Transcription Factor 4 Feedback Loop Participates in the Development of Oral Squamous Cell Carcinoma through Activation of Wnt/β-Catenin Signaling Pathway.
    Geng Z; Huang Y; Wu S; Zhu D; Li W
    Am J Pathol; 2023 Feb; 193(2):233-245. PubMed ID: 36697118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.